TetraLogic Pharmaceuticals Corporation
TLOG
TLOG was delisted on the 3rd of November, 2016.
35 hedge funds and large institutions have $43.4M invested in TetraLogic Pharmaceuticals Corporation in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 6 closing their positions.
200% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 6
52% more funds holding
Funds holding: 23 → 35 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
47% less capital invested
Capital invested by funds: $81.2M → $43.4M (-$37.8M)
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$1.38M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$760K |
| 3 |
FWC
First Washington Corp
Seattle,
Washington
|
+$656K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$600K |
| 5 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$353K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OC
Oppenheimer & Co
New York
|
-$10.2M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.51M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.42M |
| 4 |
PC
PointState Capital
New York
|
-$2.29M |
| 5 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$1.65M |
TLOG Hedge Fund Activity: Q1 2014 in Review
35 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q1 2014, worth a combined $43.4M — down 47% from $81.2M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new TLOG positions and 6 closed out — a net gain of 12 holders — while 3 added to existing stakes and 12 trimmed.
The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $1.38M. The largest seller was Oppenheimer & Co, exiting entirely with an estimated $10.2M sold.
- 35 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q1 2014, up from 23 in Q4 2013.
- Funds reported $43.4M of TetraLogic Pharmaceuticals Corporation stock for Q1 2014, down 47% quarter-over-quarter.
- 18 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q1 2014 and 6 closed out, a net change of +12 holders.
- The largest TetraLogic Pharmaceuticals Corporation buyer in Q1 2014 was First Eagle Investment Management, an estimated $1.38M added.
- The largest TetraLogic Pharmaceuticals Corporation seller in Q1 2014 was Oppenheimer & Co, an estimated $10.2M sold.
Based on aggregated 13F filings for Q1 2014.